Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Trading Statement

13 May 2008 06:09

RNS Number : 2561U
MicroEmissive Displays Group PLC
13 May 2008
 



For immediate release: 13 May 2008

MicroEmissive Displays Group plc

("MED" or "the Company")

Trading Statement & Directorate Change

MED, the AIM listed designer and manufacturer of low power microdisplays, provides the following update on current trading. 

Discussions with potential customers remain positive and MED has now shipped in excess of 100,000 units to three global headset manufacturers. In addition, the Company can also report nine recent design wins with potential customers who are in the process of designing its revolutionary product, eyescreen™ into their end products. MED is also in discussion with two of Asia's leading digital camera manufacturers regarding the further application of eyescreen™.

From a manufacturing perspective, the Dresden plant continues to perform well with manufacturing yields in line with the Board's expectations.

However, as a result of a general slow down in the demand for consumer electronics world-wide and a slower than anticipated development of the market for consumer head mounted displays, the Board now expects the Company to achieve month-on-month profitability during the next financial year. 

The Company also announces today that Paul van Eynde, Director of Sales and Marketing left the employment of MED, and the Board, on 12 May 2008. Bill Miller, Chief Executive of MED, will take responsibility for the Sales and Marketing function and Graeme Walker, Chief Financial Officer, will take responsibility for Operations whilst a permanent replacement is sought.

Commenting on outlook, Bill Miller said: "We are confident that the prospects for eyescreen™ remain very exciting indeed. The delay in the development of the market for consumer head mounted displays has been disappointing but we are still confident that the goals for MED can be met albeit slightly later than expected."

He added: "The design-in activity remains strong and feedback from customers is extremely positive, which gives us confidence in the future performance of the Company."

-ends-

For further information, please contact: www.microemissive.com

MicroEmissive Displays

Bill Miller, Chief Executive

0131 650 7764

Tavistock Communications

Matt Ridsdale

Andrew Dunn

 

020 7920 3150

Arbuthnot Securities 

Neil Kirton

John Prior

020 7012 2000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTATMRTMMABBFP
Date   Source Headline
17th Dec 20207:00 amRNSChange of ticker
2nd Dec 20207:00 amRNSChange of auditor
30th Oct 20207:00 amRNSVoluson SWIFT receives FDA clearance
30th Sep 20207:00 amRNSGE Healthcare launches new ultrasound AI software
21st Sep 20207:00 amRNSChange of Registered Office
18th Sep 20207:00 amRNSFDA filing submitted for second ScanNavAI software
16th Sep 20207:00 amRNSFormation of Nomination Committee
6th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20207:00 amRNSNotice of Results
13th Jul 20207:00 amRNSTrading Update
18th Jun 202011:30 amRNSResult of AGM
18th May 20207:00 amRNSNotice of AGM and publication of Annual Report
7th May 20205:29 pmRNSHolding(s) in Company
7th May 202011:03 amRNSHolding(s) in Company
6th May 20209:36 amRNSDirector dealings
4th May 202011:27 amRNSResult of General Meeting & Total Voting Rights
24th Apr 20202:57 pmRNSGrant of Options
22nd Apr 20207:00 amRNSBodyWorks COVID-19 Ultrasound Simulator case study
17th Apr 20203:22 pmRNSPlacing to raise £5.2m and Notice of GM
3rd Apr 20207:00 amRNSNHS Nightingale ExCel Hospital
26th Mar 20207:00 amRNSFinal Results
25th Mar 20207:00 amRNSCOVID-19 update; COVID-19 training module launch
4th Mar 20207:00 amRNSISO13485 certification for medical devices
4th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSNotice of Results
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
29th Jan 20207:00 amRNSMinisterial visit to Intelligent Ultrasound HQ
8th Jan 20207:00 amRNSTrading Update
26th Nov 20197:00 amRNSDirectorate Changes
25th Nov 20197:00 amRNSContingent Liability Update
17th Oct 20191:00 pmRNSAgreement with FUJIFILM SonoSite, Inc.
23rd Sep 20197:00 amRNSUltrasound AI database exceeds four million images
4th Sep 20197:00 amRNSClarification of change of holding
2nd Sep 201911:48 amRNSHolding(s) in Company
30th Aug 20196:17 pmRNSHolding(s) in Company
28th Aug 20195:16 pmRNSHolding(s) in Company
28th Aug 20199:12 amRNSDirector/PDMR Shareholding
27th Aug 201911:45 amRNSResult of General Meeting and Open Offer
8th Aug 20197:00 amRNSPlacing, Open Offer and Notice of General Meeting
31st Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNSCollaboration with National Imaging Academy Wales
10th Jul 20197:00 amRNSTrading update
4th Jul 20197:46 amRNSFirst OEM agreement for AI based imaging software
23rd May 20193:14 pmRNSResult of AGM
23rd May 20197:00 amRNSAGM Statement
16th May 20197:00 amRNSFirst live demonstration of ScanNav AnatomyGuide
30th Apr 20197:00 amRNSNotice of Annual General Meeting
28th Mar 20197:00 amRNSFinal Results
19th Feb 20197:00 amRNSNotice of Results
24th Jan 20197:00 amRNSInvestor presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.